GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A
GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A

产品概述
快速信息
- 产品系列
- Oligonucleotide Conjugation & Delivery Ligands
- 化学名称
- GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A
CH52004 is listed as GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A.
The catalog record does not include CAS, formula, MW, support loading, PubChem CID, or pore-size specification for the exact product.
Controlled-pore-glass supports are described in solid-phase oligonucleotide synthesis literature, and GalNAc-CPG appears in broader GalNAc conjugate discussion. Those references do not verify CH52004 support structure, loading, or performance.
身份与规格
| Catalog No. | CH52004 |
| Product Name | GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A |
| CAS No. | Not assigned |
| Formula / MW | Not listed |
| Support Loading | Not listed |
| Public CID | No public CID cited |
应用背景
- CPG support published studies for solid-phase oligonucleotide synthesis
- GalNAc ligand chemistry research
补充物料信息
用途
This catalog entry is limited to support identity information. Loading, pore size, and support-specific specifications are not included.
特性
The catalog name indicates a GalNAc cluster on a DMT succinate LCAA CPG support. Structure, loading, pore size, and support specifications are not included in the catalog record.
相关技术资源
公开来源
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency in mice
Nucleic Acids Research, 2014
Product-family technical context
- Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits RNAi-mediated gene silencing
Journal of the American Chemical Society, 2014
Product-family technical context
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
ACS Chemical Biology, 2015
Product-family technical context
- Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands
Journal of Pharmacology and Experimental Therapeutics, 2016
Product-family technical context
常见问题
What is CH52004 listed as?
CH52004 is listed as GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000 A.
Are loading and pore size verified?
No. available data treat support loading and pore-size specification as Not listed.
What context can be shown safely?
Only general CPG support and GalNAc ligand research are shown because support specifications are not included.
相似产品
需要协助选择物料?
CHEMOS 可协助评估产品匹配、目标结构、路线问题、分析要求和项目供应需求。



